Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,775,319
+$283,122 QoQ
Shares Held
7,055
+2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,059
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $29,659,281 across 14 Drug Manufacturers - General names. ABBV ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,378 | $9,300,573 | |
| 2 | JNJ |
Johnson & Johnson
|
32,347 | $8,215,167 | |
| 3 | LLY |
ELI LILLY & Co
|
5,315 | $6,374,970 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
7,055 | $1,775,319 | |
| 5 | AMGN |
Amgen Inc
|
3,021 | $1,093,963 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,923 | $874,651 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,930 | $687,405 | |
| 8 | NVS |
Novartis AG
|
4,070 | $637,849 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,775,319 | 7,055 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,492,197 | 6,861 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,648,097 | 7,213 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $1,671,718 | 7,220 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,467,140 | 7,904 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,651,855 | 7,884 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,296,854 | 7,298 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,440,616 | 7,295 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,001,161 | 5,837 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,002,824 | 5,507 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $761,522 | 4,914 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $786,439 | 5,276 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $651,958 | 4,839 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $788,402 | 4,947 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $751,808 | 4,652 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $595,220 | 4,435 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $697,336 | 4,553 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $677,456 | 4,179 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $588,448 | 4,346 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $633,736 | 5,875 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $548,669 | 4,871 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $711,329 | 6,573 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $467,924 | 4,367 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $376,549 | 4,299 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $420,406 | 4,282 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $313,217 | 4,111 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||